86 datasets and encompassing 15,249 samples, incl:
-Breast cancer: 39 microarray datasets from a variety of commercially available microarray platforms
-Ovarian cancer: 26 microarray datasets spanning 3,526 samples
-Pancreatic cancer: 21 datasets with a total of 1,719 patient transcriptomic profiles
MetaGxData package compendium, which includes manually-curated and standardized clinical, pathological, survival, and treatment metadata across breast, ovarian, and pancreatic cancer data.
Who uses it
Cancer researchers interested in using transcriptomic and clinical data in a variety of cross-tumor analyses, e.g. identification of common biomarkers, and assessing the validity of prognostic signatures.
Why we like this
MetaGxData is the largest compendium of curated transcriptomic data for breast, ovarian, and pancreatic cancer to date.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.